CDC reported that 6.9% of U.S. adults have long COVID, and the ADDRESS-LC trial is enrolling patients.
1 report, 1 independent
Updated Aug 14
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
CDC reported that 6.9% of U.S. adults have long COVID, and the ADDRESS-LC trial is enrolling patients.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Centers for Disease Control
governmental medical research institute with headquarters in Taipei, Taiwan
-
Biovie
French company founded in 2007, specializing in online sales of organic, raw, and living foods, committed to education on healthy eating.
Nothing else this week.
Coverage
Newest first; wire copies grouped- GlobeNewswireBioVie Highlighted ADDRESS-LC Phase 2 Trial Design Exploring Bezisterim for the Treatment of Neurological Symptoms of Long COVID at Keystone Symposia on Long COVID and Other Post-Acute Infection Syndr